Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP(31-67) measurements in chronic heart failure: a useful index for heart trasplantation?

Citation
E. Cappellin et al., Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP(31-67) measurements in chronic heart failure: a useful index for heart trasplantation?, CLIN CHIM A, 310(1), 2001, pp. 49-52
Citations number
6
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICA CHIMICA ACTA
ISSN journal
00098981 → ACNP
Volume
310
Issue
1
Year of publication
2001
Pages
49 - 52
Database
ISI
SICI code
0009-8981(20010801)310:1<49:PANP(F>2.0.ZU;2-9
Abstract
The family of the atrial natriuretic peptides, proANP fragments and the act ive alpha ANP, is strongly related to heart disease. The aim was to study i n CHF subjects the relation of mdANP and NtANP with brain natriuretic pepti de (BNP) and with other traditional medical parameters. Sixteen CHF patient s (aged 51.9 +/- 13.7 years) and 16 healthy subjects age matched (50.8 +/-5 .9 years) were selected. Both NtANP and mdANP were higher in CHF patients t han in healthy subjects (1436 +/- 288 vs. 288 +/- 22 pmol/l p<0.001 and 230 5<plus/minus>383 vs. 423 +/- 65 pmol/l p<0.0001, respectively). BNP in CHF patients was 28.0<plus/minus>9 pmol/l (reference values 1.7 +/-1.8 pmol/l). Both NtANP and mdANP demonstrated positive correlation with BNP, p<0.0001 and with left atrial end-systolic volume, p<0.05. BNP correlated with left ventricular mass, p<0.03. In conclusion, plasma NtANP and mdANP analyses ar e useful laboratory markers in CHF patient investigation and follow up. In particular, they could be employed as non-invasive parameters to follow up worsening of systolic dysfunction until heart transplantation is required. (C) 2001 Elsevier Science BN. All rights reserved.